184 related articles for article (PubMed ID: 26754405)
21. EZH2 overexpression is associated with poor prognosis in patients with glioma.
Zhang Y; Yu X; Chen L; Zhang Z; Feng S
Oncotarget; 2017 Jan; 8(1):565-573. PubMed ID: 27880940
[TBL] [Abstract][Full Text] [Related]
22. Nestin is significantly associated with the overall survival of nonsmall cell lung cancer: A meta-analysis.
Zhang D; Wang J
J Cancer Res Ther; 2020; 16(4):800-803. PubMed ID: 32930121
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
[TBL] [Abstract][Full Text] [Related]
24. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.
Liang Y; Guo S; Zhou Q
Tumour Biol; 2014 Apr; 35(4):3717-24. PubMed ID: 24338766
[TBL] [Abstract][Full Text] [Related]
27. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
28. Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.
Tong J; Sun X; Cheng H; Zhao D; Ma J; Zhen Q; Cao Y; Zhu H; Bai J
Lung Cancer; 2011 Nov; 74(2):155-63. PubMed ID: 21621871
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of FoxM1 expression in non-small cell lung cancer.
Sun Q; Dong M; Chen Y; Zhang J; Qiao J; Guo X
J Thorac Dis; 2016 Jun; 8(6):1269-73. PubMed ID: 27293846
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis.
Zhan P; Wang J; Lv XJ; Wang Q; Qiu LX; Lin XQ; Yu LK; Song Y
J Thorac Oncol; 2009 Sep; 4(9):1094-103. PubMed ID: 19687765
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
Fang J; Sun CC; Gong C
Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
[TBL] [Abstract][Full Text] [Related]
32. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
[TBL] [Abstract][Full Text] [Related]
33. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
Behrens C; Solis LM; Lin H; Yuan P; Tang X; Kadara H; Riquelme E; Galindo H; Moran CA; Kalhor N; Swisher SG; Simon GR; Stewart DJ; Lee JJ; Wistuba II
Clin Cancer Res; 2013 Dec; 19(23):6556-65. PubMed ID: 24097870
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.
Wang J; Wang B; Zhao W; Guo Y; Chen H; Chu H; Liang X; Bi J
PLoS One; 2012; 7(12):e52704. PubMed ID: 23285161
[TBL] [Abstract][Full Text] [Related]
35. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
36. PD-L1 over-expression is associated with a poor prognosis in Asian non-small cell lung cancer patients.
Xia H; Shen J; Hu F; Chen S; Huang H; Xu Y; Ma H
Clin Chim Acta; 2017 Jun; 469():191-194. PubMed ID: 28188721
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
[TBL] [Abstract][Full Text] [Related]
38. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
39. Role of EZH2 protein expression in gastric carcinogenesis among Asians: a meta-analysis.
Guo L; Yang TF; Liang SC; Guo JX; Wang Q
Tumour Biol; 2014 Jul; 35(7):6649-56. PubMed ID: 24705718
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis.
Wang Q; Xu L; Wang G; Chen L; Li C; Jiang X; Gao H; Yang B; Tian W
PLoS One; 2020; 15(11):e0241241. PubMed ID: 33186371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
